News
Tuesday, September 11, 2012
Screening for Ovarian Cancer Only Recommended for Women with Known Genetic Risk
Friday, May 25, 2012
Independant validation study confirms that the KRAS-variant predicts breast and ovarian cancer risk
Tuesday, December 6, 2011
Mira Dx highlights breakthrough publication describing a marker for resistance to Platinum treatment in Ovarian Cancer